Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
COVID-19 News New study finds strong immune response following COVID-19 vaccination A new study carried out in collaboration with the University of Birmingham with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine.
COVID-19 New gene therapy innovation centre to advance scientific discoveries into life-changing treatments
Posted 29 July 2021 Birmingham cancer project enters Immuno-oncology Alliance Birmingham researchers partnered with Cancer Research UK in one of the first target identification projects for the Immuno-oncology Alliance, which translates discovery science into new therapeutics for cancer patients.
Posted 23 July 2021 Longer interval between the first and second Pfizer vaccine boosts antibody levels and 'helper' T cells A new study carried out in collaboration with the University of Birmingham shows both short and long dosing schedules of the Pfizer COVID-19 vaccine generate strong antibody and T cell immune responses.
Posted 13 July 2021 Partnership will create the next generation of researchers to transform global healthcare The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
Posted 07 July 2021 Cancer Research UK Advanced Clinician Scientist shares top tips on undertaking research Dr Shishir Shetty is a Cancer Research UK Advanced Clinician Scientist and principal investigator in the Centre for Liver and Gastrointestinal Research.
Posted 25 June 2021 Congress focuses on impact of COVID-19 on global liver disease University of Birmingham experts are among the leading liver disease researchers gathering at the virtual 2021 International Liver Congress to discuss the impact of the COVID-19 pandemic on people with liver disease.
Posted 11 June 2021 Fighting the silent pandemic of anti-microbial resistance An open letter to the G7 from the BactiVac Network emphasising the need for a global effort to combat the threat posed by anti-microbial resistant bacteria.